KVP Capital Advisors, LP — 13F Holdings & Portfolio
CIK 1858198 · latest 13F-HR filed 2026-08-13
KVP Capital Advisors, LP manages $136.2M in 13F-reported U.S. long-equity assets across 35 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PRAX (10.54%), WHWK (7.28%), ERAS (6.12%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 6 new positions, exited 3, added to 18, and trimmed 7.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$136.2M
Long-equity book
35
Distinct positions
2026-06-30
Filed 2026-08-13
+6 / −3 / ↑18 / ↓7
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Share-count changes vs the prior 13F.
Top Adds (vs prior quarter)
- MBX BIOSCIENCES INC$3.1M +84.9%
- ERASCA INC$2.8M +51.5%
- TREVI THERAPEUTICS INC$2.8M +56.3%
- WHITEHAWK THERAPEUTICS INC$2.4M +32.8%
- TANGO THERAPEUTICS INC$2.4M +49.4%
Top Trims
- AXSOME THERAPEUTICS INC.-$3.2M -52.0%
- INSMED INC-$1.6M -34.8%
- COMPASS THERAPEUTICS INC-$956.5K -36.2%
- TRAVERE THERAPEUTICS INC-$488.0K -18.1%
- UNITED THERAPEUTICS CORP DEL-$243.0K -8.6%
New Positions
- TANDEM DIABETES CARE INC$4.5M
- ARRIVENT BIOPHARMA INC$3.5M
- DESIGN THERAPEUTICS INC$2.7M
- MINERALYS THERAPEUTICS INC$2.3M
- ARTIVA BIOTHERAPEUTICS INC$1.9M
Exited Positions
- TERNS PHARMACEUTICALS INC$23.2M
- REVOLUTION MEDICINES INC$3.9M
- SOLENO THERAPEUTICS INC$2.0M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $14.4M | 10.54% | 42,900 | SH |
| 2 | WHITEHAWK THERAPEUTICS INC | WHWK | 00032Q104 | $9.9M | 7.28% | 2,165,997 | SH |
| 3 | ERASCA INC | ERAS | 29479A108 | $8.3M | 6.12% | 455,000 | SH |
| 4 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $7.7M | 5.67% | 414,000 | SH |
| 5 | SUTRO BIOPHARMA INC | STRO | 869367201 | $7.5M | 5.52% | 226,575 | SH |
| 6 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $7.2M | 5.28% | 230,264 | SH |
| 7 | MBX BIOSCIENCES INC | MBX | 55287L101 | $6.7M | 4.92% | 121,524 | SH |
| 8 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $6.5M | 4.77% | 53,000 | SH |
| 9 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $5.4M | 3.97% | 133,000 | SH |
| 10 | TANDEM DIABETES CARE INC | TNDM | 875372203 | $4.5M | 3.33% | 301,000 | SH |
| 11 | DISC MEDICINE INC | IRON | 254604101 | $4.3M | 3.13% | 58,250 | SH |
| 12 | SAVARA INC | SVRA | 805111101 | $3.7M | 2.74% | 605,280 | SH |
| 13 | ARRIVENT BIOPHARMA INC | AVBP | 04272N102 | $3.5M | 2.60% | 102,000 | SH |
| 14 | INSMED INC | INSM | 457669307 | $3.0M | 2.23% | 28,497 | SH |
| 15 | ACHIEVE LIFE SCIENCES INC | ACHV | 004468500 | $3.0M | 2.22% | 462,355 | SH |
| 16 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $3.0M | 2.18% | 79,700 | SH |
| 17 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $2.9M | 2.16% | 300,000 | SH |
| 18 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $2.9M | 2.16% | 12,000 | SH |
| 19 | DESIGN THERAPEUTICS INC | DSGN | 25056L103 | $2.7M | 1.96% | 185,000 | SH |
| 20 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $2.6M | 1.89% | 4,750 | SH |
| 21 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $2.5M | 1.82% | 45,000 | SH |
| 22 | IMMIX BIOPHARMA INC | IMMX | 45258H106 | $2.4M | 1.74% | 230,423 | SH |
| 23 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $2.3M | 1.69% | 125,000 | SH |
| 24 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $2.3M | 1.67% | 84,168 | SH |
| 25 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $2.2M | 1.64% | 31,813 | SH |
| 26 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $2.2M | 1.63% | 39,000 | SH |
| 27 | ZURA BIO LTD | ZURA | G9TY5A101 | $2.2M | 1.62% | 373,128 | SH |
| 28 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 04317A107 | $1.9M | 1.42% | 200,000 | SH |
| 29 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $1.9M | 1.38% | 26,900 | SH |
| 30 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $1.7M | 1.24% | 771,000 | SH |
| 31 | CABALETTA BIO INC | CABA | 12674W109 | $1.6M | 1.15% | 505,431 | SH |
| 32 | VERA THERAPEUTICS INC | VERA | 92337R101 | $1.4M | 1.03% | 32,700 | SH |
| 33 | EVOLUS INC | EOLS | 30052C107 | $1.0M | 0.76% | 150,000 | SH |
| 34 | CELCUITY INC | CELC | 15102K100 | $418.5K | 0.31% | 4,000 | SH |
| 35 | VYNE THERAPEUTICS INC | VYNE | 92941V308 | $325.7K | 0.24% | 500,551 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-13 | $136.2M | 35 | 0001104659-26-095988 |
| 2026-03-31 | 2026-05-13 | $133.9M | 32 | 0001104659-26-060329 |
| 2025-12-31 | 2026-02-18 | $103.3M | 27 | 0001104659-26-016901 |
SUITE 2100
SAN FRANCISCO, CA 94111